Welcome to the international HTA database

Showing [21797 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2022	The Regional Health Technology Assessment Centre (HTA-centrum)	[Benefits and risks of caseload midwifery: continuity of midwifery team during antenatal, intrapartal, and postnatal care]
2022	NIHR Health Technology Assessment programme	Accuracy of a rapid intrapartum test for maternal group B streptococcal colonisation and its potential to reduce antibiotic usage in mothers with risk factors (GBS2)
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: integration of real-world data and evidence into assessments to support decision-making in the pharmaceutical sector]
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Quality registries in dementia care: mapping of registries to improve quality and service delivery
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Digital breast tomosynthesis]
2022	The Regional Health Technology Assessment Centre (HTA-centrum)	Active or semi-active robotic arm-assisted versus manual knee arthroplasty: benefits and risks
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Medications for treating moderate to severe alcohol withdrawal syndrome in critical care and emergency department patients
2022	Malaysian Health Technology Assessment (MaHTAS)	Molecular profiling assays in early breast cancer
2022	The Regional Health Technology Assessment Centre (HTA-centrum)	Effectiveness and safety of surgical procedures to treat apical prolapse - comparison of sacrospinous fixation, laparoscopic sacrocolpopexy/sacrohysteropexy, and the Manchester procedure
2022	NIHR Health Technology Assessment programme	Paclitaxel assisted balloon Angioplasty of Venous stenosis in haEmodialysis access: The PAVE Trial. A multicentre double-blind randomised controlled trial in haemodialysis patients with a stenosis in a native arteriovenous fistula
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines and clinical pathways for management of upper GI bleeding
2022	Malaysian Health Technology Assessment (MaHTAS)	Immunotherapy for PD-L1 positive advanced non-small cell lung cancer
2022	NIHR Health Technology Assessment programme	Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Peripartum or postnatal care disparities and equity
2022	Malaysian Health Technology Assessment (MaHTAS)	Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for non-small cell lung cancer
2022	NIHR Health Technology Assessment programme	EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
2022	Malaysian Health Technology Assessment (MaHTAS)	Robotic arm-assisted surgery in total hip arthroplasty, total knee arthroplasty and unicompartmental knee arthroplasty
2022	NIHR Health Technology Assessment programme	Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation (LiverTOL-Dx Trial)
2022	WorkSafeBC	Clinical accuracy of rapid antigen tests for COVID-19
2022	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Ambulatory blood pressure monitoring (ABPM) in the identification of circadian patterns in patients with arterial hypertension: evaluation of safety, effectiveness, and efficiency]
2022	NIHR Health Technology Assessment programme	Unspecified living kidney donation in the UK: barriers to implementation and delivery
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Workplace violence in healthcare settings
2022	WorkSafeBC	Functional neurology as treatment for post-traumatic brain injury
2022	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of the safety, efficacy/effectiveness, and efficiency of teleconsultation in primary care, and the organizational, ethical, social, and legal aspects linked to its use]
2022	NIHR Health Technology Assessment programme	Delivering primary health care to homeless people: an evaluation of the integration, effectiveness and costs of different models
2022	Health Technology Wales (HTW)	Electronic blood management systems for blood transfusions
2022	WorkSafeBC	Dupuytren's contracture and wrist fractures
2022	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of the safety, efficacy/effectiveness, and efficiency of stereotactic body radiation therapy (SBRT) in lung, prostate, and liver cancer]
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: evaluation of Synvisc and Synvisc One for the management of knee osteoarthritis]
2022	WorkSafeBC	Percussion therapy for neuropathic pain
2022	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Stereotactic radiosurgery for the treatment of epilepsy, essential tremor, Parkinson's disease, glossopharyngeal and trigeminal neuralgia: synthesis of its efficacy, effectiveness, safety, and efficiency]
2022	National Authority for Assessment and Accreditation in Healthcare (INEAS)	[SKYRIZI® (Risankizumab) for the treatment of moderate to severe plaque psoriasis in adults : A rapid review]
2022	NIHR Health Technology Assessment programme	The START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the effectiveness of a manual based coping strategy programme in promoting the mental health of carers of people with dementia - cohort follow-up
2022	NIHR Health Technology Assessment programme	Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation
2022	WorkSafeBC	Ketamine infusion therapy for hyperalgesia and or central sensitivity pain
2022	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Primary bariatric endoscopic techniques in adults with or without type 2 diabetes mellitus. Efficacy, effectiveness, and safety]
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: use of electrodiagnostic testing in the neurological investigation - electromyography and nerve conduction studies]
2022	Health Technology Wales (HTW)	Stereotactic ablative radiotherapy (SABR) for the treatment of renal cell carcinoma
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: KamRAB (human rabies immunoglobulin) – passive and transient postexposure prophylaxis of rabies infection]
2022	NIHR Health Technology Assessment programme	Oral nutritional interventions in frail older people who are malnourished or at risk of malnutrition: a systematic review
2022	NIHR Health Technology Assessment programme	Treatment of Barth Syndrome by CARDIOlipin MANipulation (CARDIOMAN): a randomised placebo-controlled pilot trial conducted by the nationally commissioned Barth Syndrome Service
2022	NIHR Health Technology Assessment programme	Determining optimal strategies for primary prevention of cardiovascular disease: systematic review of cost-effectiveness analyses in the United Kingdom
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Home enteral nutrition in older patients with severe protein-energy malnutrition after hip fracture]
2022	NIHR Health Services and Delivery Research programme	Understanding the potential factors affecting carers’ mental health during end-of-life home care: a meta synthesis of the research literature
2022	NIHR Health Technology Assessment programme	Shock-absorbing flooring for fall-related injury prevention in older adults and staff in hospitals and care homes: the SAFEST systematic review
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2022	NIHR Health Technology Assessment programme	Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study
2022	Scottish Health Technologies Group (SHTG)	Closed loop systems and the artificial pancreas for type I diabetes mellitus (T1DM)
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Perinatal and infant mental health care models and pathways
2022	WorkSafeBC	Environmental exposure to respirable particles and estimated risk of sarcoidosis
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: next-generation sequencing (NGS) panels for muscle disease]
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Assessment and clinical management of self-harm in adolescence: evidence-based protocol]
2022	WorkSafeBC	Tinnitus and the COVID-19 vaccine
2022	Agency for Healthcare Research and Quality (AHRQ)	Acute treatments for episodic migraine
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis by NAAT]
2022	Malaysian Health Technology Assessment (MaHTAS)	Early cancer detection test for lung (EarlyCDT-Lung)
2022	WorkSafeBC	Vision therapy as treatment for traumatic brain injury: 2022 update
2022	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[The use of social media and electronic communication in the delivery of youth protection services to young people in difficulty and their families]
2022	NIHR Health Services and Delivery Research programme	Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations
2022	Health Technology Wales (HTW)	Laryngeal biopsies in the outpatient setting in people with suspected head and neck dysplasia/cancer
2022	WorkSafeBC	Inpatient versus outpatient programs as treatment for PTSD
2022	NIHR Health Technology Assessment programme	Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis
2022	WorkSafeBC	Oral collagen supplements for shoulder sprain strain
2022	Agency for Healthcare Research and Quality (AHRQ)	Antibody response following SARS-CoV-2 infection and implications for immunity: a living rapid review
2022	NIHR Health Technology Assessment programme	REVascularisation of Ischaemic VEntricular Dysfunction (REVIVED): a randomised comparison of percutaneous coronary intervention (with optimal medical therapy) vs. optimal medical therapy alone for heart failure secondary to coronary disease
2022	Gesundheit Osterreich GmbH (GOeG)	[Cost effectiveness of communication training for health care professionals]
2022	WorkSafeBC	Convergence insufficiency and COVID-19 infection
2022	NIHR Health Technology Assessment programme	Improving the prediction of metastatic disease in primary colorectal cancer: Prospective multicentre evaluation of a prognostic model of conventional predictive variables and novel variables derived from perfusion computed tomography (Perfusion CT)
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Bronchial thermoplasty in severe asthma]
2022	Malaysian Health Technology Assessment (MaHTAS)	First line targeted therapy for advanced hepatocellular carcinoma (aHCC)
2022	WorkSafeBC	Lose-dose naltrexone as treatment for post-COVID conditions
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Radiofrequency ablation for treatment of symptomatic uterine myomas]
2022	Scottish Health Technologies Group (SHTG)	vCreate Neuro for the diagnosis and treatment of adults and children with epilepsy and other neurological disorders
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Magnetic sphincter augmentation for gastrooesophageal reflux disease (Addendum to Commission E21-06)]
2022	NIHR Health Technology Assessment programme	Enhancing social-emotional health and wellbeing in the early years: a community-based randomised controlled trial (and economic) evaluation of the Incredible Years Infant and Toddler (0-2) Parenting Programmes
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Magnetic sphincter augmentation for gastrooesophageal reflux disease]
2022	NIHR Health Technology Assessment programme	Development and evaluation of machine learning methods in whole body magnetic resonance imaging with diffusion weighted imaging for staging of patients with cancer (MAchine Learning In whole Body Oncology, MALIBO)
2022	NIHR Health Technology Assessment programme	Endometrial scratch to increase live birth rates in women undergoing first-time in vitro fertilisation: RCT and systematic review
2022	Agency for Care Effectiveness (ACE)	Revivent TC transcatheter ventricular enhancement system for ischemic heart failure
2022	NIHR Health Technology Assessment programme	FEMME trial: Randomised trial of treating Fibroids with either Embolisation or MyoMectomy to measure the Effect on quality of life
2022	Agency for Care Effectiveness (ACE)	Vagus nerve stimulation with the VITARIA System for heart failure with reduced ejection fraction
2022	Agency for Care Effectiveness (ACE)	Caption guidance to guide image acquisition in point-of-care echocardiography for patients with cardiovascular disease
2022	NIHR Health Technology Assessment programme	A randomised, multi-stage phase II/III study of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal cancer (the STAR trial)
2022	Agency for Care Effectiveness (ACE)	The PrecivityAD test for the prognosis of Alzheimer's disease
2022	The Federal Joint Committee (G-BA)	Pharmaceutical Directive/Annex XII: Voxelotor (haemolytic anaemia in sickle cell disease, monotherapy or combination with hydroxycarbamide, ≥ 12 years)
2022	NIHR Health Technology Assessment programme	Fast-Forward: a randomised clinical trial testing a 1-week course of curative whole breast radiotherapy against a standard 3-week schedule in terms of local cancer control and late adverse effects in women with early breast cancer
2022	Basque Office for Health Technology Assessment (OSTEBA)	[Autism spectrum disorder: scientific evidence on its detection, diagnosis and treatment]
2022	Agency for Care Effectiveness (ACE)	Artificial intelligence and its clinical applications
2022	The Federal Joint Committee (G-BA)	Pharmaceutical Directive/Annex XII: Avapritinib (new therapeutic indication: systemic mastocytosis, after at least 1 prior therapy)
2022	Basque Office for Health Technology Assessment (OSTEBA)	[Image-guided spinal fusion technology]
2022	Agency for Care Effectiveness (ACE)	3D printing and its clinical applications
2022	Basque Office for Health Technology Assessment (OSTEBA)	[Temporary percutaneous circulatory support devices for the treatment and prevention of cardiogenic shock: analysis of efficacy, effectiveness and safety]
2022	Agency for Care Effectiveness (ACE)	Overview of clinical applications of telemedicine
2022	The Federal Joint Committee (G-BA)	Pharmaceutical Directive/Annex XII: Tebentafusp (uveal melanoma, HLA-A*02:01-positive)
2022	Agency for Care Effectiveness (ACE)	Bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears
2022	The Federal Joint Committee (G-BA)	Pharmaceutical Directive/Annex XII: Glucarpidase (reduction of toxic plasma methotrexate concentrations; aged 28 days and older)
2022	The Federal Joint Committee (G-BA)	Pharmaceutical Directive/Annex XII: Idebenone (reassessment after the deadline: Leber's Hereditary Optic Neuropathy)
2022	Agency for Healthcare Research and Quality (AHRQ)	Diagnostic errors in the emergency department: a systematic review
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: amyotrophic lateral sclerosis with or without frontotemporal dementia NGS panel]
2022	Scottish Health Technologies Group (SHTG)	The Psychology Adding Value – Epilepsy Screening (PAVES) and early intervention for children and young people with epilepsy at risk of mental health problems